Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of the anesthetic.
Why Drug Companies Are Rushing to Market Ketamine Medicines
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Undeciphered Voynich manuscript may have been bound out of order, study finds
Experts argue that the mysterious Voynich manuscript was incorrectly bound — a discovery that "moves the ball" in finall...
Ultrasound waves that jiggle deep brain structures may relieve delusions in schizophrenia, small trial hints
In a new pilot study, 10 minutes of transcranial ultrasound stimulation reduced patients' delusion severity, scientists ...
The view from the edge of a sparkling spiral galaxy | Space photo of the day for Oct. 20, 2026
If you were approaching the edge of a spiral galaxy, arriving from afar through the cosmos, it might look something like...
Red light, white light: How to preserve your night vision while using stargazing apps
The right apps can take a lot of the work out of stargazing, but they can also stop your eyes from adjusting to the dark...